Latest Insider Transactions at Teladoc Health, Inc. (TDOC)
This section provides a real-time view of insider transactions for Teladoc Health, Inc. (TDOC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Teladoc Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Teladoc Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 25
2021
|
Sandra L Fenwick Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,173
+33.33%
|
-
|
|
Feb 19
2021
|
Catherine Jacobson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
734
+50.0%
|
-
|
|
Feb 16
2021
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
SELL
Open market or private sale
|
Direct |
1,750
-1.71%
|
$521,500
$298.26 P/Share
|
|
Feb 16
2021
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,750
+1.68%
|
$3,500
$2.73 P/Share
|
|
Feb 10
2021
|
Daniel Trencher CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
3,000
-26.29%
|
$870,000
$290.49 P/Share
|
|
Feb 10
2021
|
Daniel Trencher CHIEF STRATEGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+20.81%
|
$66,000
$22.3 P/Share
|
|
Feb 03
2021
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
SELL
Open market or private sale
|
Direct |
2,610
-92.88%
|
$702,090
$269.85 P/Share
|
|
Feb 03
2021
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
2,610
+38.03%
|
$78,300
$30.42 P/Share
|
|
Feb 02
2021
|
Jason N Gorevic CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
30,000
-5.38%
|
$8,130,000
$271.06 P/Share
|
|
Feb 01
2021
|
Stephany Verstraete CHIEF MARKETING OFFICER |
SELL
Open market or private sale
|
Direct |
7,000
-34.52%
|
$1,855,000
$265.02 P/Share
|
|
Feb 01
2021
|
Stephany Verstraete CHIEF MARKETING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+25.66%
|
$154,000
$22.3 P/Share
|
|
Feb 01
2021
|
Glen Tullman Director |
SELL
Open market or private sale
|
Direct |
164,931
-37.42%
|
$43,211,922
$262.61 P/Share
|
|
Feb 01
2021
|
Glen Tullman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
164,931
+27.23%
|
$824,655
$5.26 P/Share
|
|
Jan 25
2021
|
Yulun Wang Head of Research & Development |
SELL
Open market or private sale
|
Indirect |
8,261
-3.63%
|
$2,313,080
$280.0 P/Share
|
|
Jan 22
2021
|
Yulun Wang Head of Research & Development |
SELL
Open market or private sale
|
Indirect |
8,000
-3.39%
|
$2,080,000
$260.0 P/Share
|
|
Jan 20
2021
|
Yulun Wang Head of Research & Development |
SELL
Open market or private sale
|
Indirect |
8,000
-3.28%
|
$1,920,000
$240.0 P/Share
|
|
Jan 14
2021
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
SELL
Open market or private sale
|
Direct |
1,750
-1.71%
|
$395,500
$226.66 P/Share
|
|
Jan 14
2021
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,750
+1.68%
|
$3,500
$2.73 P/Share
|
|
Jan 14
2021
|
Yulun Wang Head of Research & Development |
SELL
Open market or private sale
|
Indirect |
8,000
-3.18%
|
$1,808,000
$226.66 P/Share
|
|
Jan 14
2021
|
Glen Tullman Director |
SELL
Open market or private sale
|
Direct |
164,931
-37.42%
|
$37,109,475
$225.12 P/Share
|
|
Jan 14
2021
|
Glen Tullman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
164,931
+27.23%
|
$824,655
$5.26 P/Share
|
|
Jan 11
2021
|
Daniel Trencher CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
3,000
-26.29%
|
$681,000
$227.33 P/Share
|
|
Jan 11
2021
|
Daniel Trencher CHIEF STRATEGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+20.81%
|
$66,000
$22.3 P/Share
|
|
Jan 06
2021
|
Stephany Verstraete CHIEF MARKETING OFFICER |
SELL
Open market or private sale
|
Direct |
3,000
-18.43%
|
$612,000
$204.0 P/Share
|
|
Jan 06
2021
|
Stephany Verstraete CHIEF MARKETING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+15.56%
|
$66,000
$22.3 P/Share
|
|
Jan 05
2021
|
Jason N Gorevic CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
30,000
-5.11%
|
$6,000,000
$200.15 P/Share
|
|
Jan 04
2021
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
SELL
Open market or private sale
|
Direct |
2,529
-92.67%
|
$503,271
$199.8 P/Share
|
|
Jan 04
2021
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
2,529
+37.58%
|
$75,870
$30.42 P/Share
|
|
Jan 04
2021
|
Stephany Verstraete CHIEF MARKETING OFFICER |
SELL
Open market or private sale
|
Direct |
4,000
-23.15%
|
$796,000
$199.8 P/Share
|
|
Jan 04
2021
|
Stephany Verstraete CHIEF MARKETING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+18.8%
|
$88,000
$22.3 P/Share
|
|
Dec 15
2020
|
Yulun Wang Head of Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+50.0%
|
$72,000
$16.92 P/Share
|
|
Dec 14
2020
|
Yulun Wang Head of Research & Development |
SELL
Open market or private sale
|
Direct |
2,500
-100.0%
|
$497,500
$199.24 P/Share
|
|
Dec 14
2020
|
Yulun Wang Head of Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+50.0%
|
$40,000
$16.92 P/Share
|
|
Dec 10
2020
|
Daniel Trencher CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
3,000
-26.29%
|
$576,000
$192.17 P/Share
|
|
Dec 10
2020
|
Daniel Trencher CHIEF STRATEGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+20.81%
|
$66,000
$22.3 P/Share
|
|
Dec 08
2020
|
Hemant Taneja Director |
SELL
Open market or private sale
|
Indirect |
4,900
-100.0%
|
$965,300
$197.39 P/Share
|
|
Dec 04
2020
|
Stephany Verstraete CHIEF MARKETING OFFICER |
SELL
Open market or private sale
|
Direct |
2,000
-13.09%
|
$408,000
$204.0 P/Share
|
|
Dec 04
2020
|
Stephany Verstraete CHIEF MARKETING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+11.58%
|
$44,000
$22.3 P/Share
|
|
Dec 04
2020
|
Yulun Wang Head of Research & Development |
SELL
Open market or private sale
|
Direct |
6,069
-100.0%
|
$1,213,800
$200.0 P/Share
|
|
Dec 04
2020
|
Yulun Wang Head of Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
6,069
+50.0%
|
$97,104
$16.92 P/Share
|
|
Dec 03
2020
|
Jason N Gorevic CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
5,000
-0.82%
|
$1,000,000
$200.52 P/Share
|
|
Dec 03
2020
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
SELL
Open market or private sale
|
Direct |
1,389
-25.7%
|
$277,800
$200.0 P/Share
|
|
Dec 03
2020
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
BUY
Exercise of conversion of derivative security
|
Direct |
1,389
+20.45%
|
$30,558
$22.3 P/Share
|
|
Dec 03
2020
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
SELL
Open market or private sale
|
Direct |
2,611
-92.89%
|
$511,756
$196.5 P/Share
|
|
Dec 03
2020
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
2,611
+38.03%
|
$78,330
$30.4 P/Share
|
|
Dec 01
2020
|
Stephany Verstraete CHIEF MARKETING OFFICER |
SELL
Open market or private sale
|
Direct |
4,000
-23.15%
|
$792,000
$198.66 P/Share
|
|
Dec 01
2020
|
Stephany Verstraete CHIEF MARKETING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+18.8%
|
$88,000
$22.3 P/Share
|
|
Dec 01
2020
|
Jason N Gorevic CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
25,000
-3.92%
|
$4,850,000
$194.27 P/Share
|
|
Nov 27
2020
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
SELL
Open market or private sale
|
Direct |
3,924
-3.75%
|
$761,256
$194.89 P/Share
|
|
Nov 25
2020
|
Sandra L Fenwick Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,173
+16.8%
|
-
|